Biotechnology Industry Organization

BIOtech Now’s Tracy Krughoff talks to Dr. David Agus of the University of Southern California’s Westside Prostate Cancer Center and the Center for Applied Molecular Medicine. His research focuses on the application of proteomics and genomics for the study of cancer and the development of new therapeutics for prostate cancer. Dr. Agus also is one of the judges for the Biotechnology Humanitarian Award, which will be given at the 2010 BIO International Convention.

Listen to the podcast:
http://www.bio.org/podcasts/agus.wma

Patient advocacy groups have many different roles.  They are educators, they provide a support system for individuals and families of people living with illness, they lobby for increased research, and are increasingly providing funding to biotech companies to encourage further research and development of promising, and potentially life-saving therapies.  At the 2009 BIO International Convention, we met with patients  and patient advocates to learn more about how advocacy groups are working together with biotech researchers to promote innovative research and creation of therapies that may one d

Biotech Now’s Tracy Krughoff talks to Dr. Marc Hurlbert, who is Director of the Avon Foundation Breast Cancer Crusade.

Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, there are a few important safeguards that must be put into place before these “similar but not the same” versions of biologics can be safely introduced to the public.  Join Dr.

Biotech Now’s Tracy Krughoff talks to Dr. Lynn Johnson Langer, who is Senior Associate Program Chair at the Center for Biotechnology Education www.biotechnology.jhu.edu at Johns Hopkins University.

What do pandas, bantengs, and panthers have in common?  Their populations have all been assisted by biotechnology.  Whether endangered, or unhealthy due to a lack of biodiversity, advances in biotechnology - including animal cloning and assisted reproductive technologies, have helped these animals, and many others, to increase their populations, become healthier, and enjoy a more genetically diverse environment.

Download to listen or view the podcast.

Do you ever wonder if the medicine you're taking is really helping to make you feel better? What if your doctor had a way to tell you exactly which drug and what dosage would best treat your illness?  Dr.

Dr. Targan explains how the biotech industry is using the biology of taste to create healthier sweeteners, block bitter tastes, and help make unpleasant-tasting medicines more palatable.

Download to listen or view the podcast.